Todd Davis

Todd C Davis is the Founder and Managing Partner of RoyaltyRx Capital, a special opportunities investment firm. He has almost thirty years of experience in both operations and investing in the biopharmaceutical and life science industries and from 2006 until 2018, was a Founder & Managing Partner of Cowen/HealthCare Royalty Partners, a global healthcare investment firm. Mr. Davis has been involved in over $3 billion in healthcare financings including growth equity, public equity turnarounds, structured debt and royalty acquisitions, and has also led, structured and closed over 40 additional intellectual property licenses, as well as hybrid royalty-debt deals. Mr. Davis holds a B.S. from the U.S. Naval Academy and an M.B.A. from Harvard University. He currently serves on the boards of Palvella Therapeutics Inc., BioDelivery Sciences, Ligand Pharmaceuticals and the Harvard Business School Healthcare Alumni Association.